Search Results
Results found for "Kevin Pfleger"
- Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed...
December 2021 Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was Coincidentally, on the same day, Prof Pfleger was announced as a Fellow of the British Pharmacological Prof Pfleger has served on the ASCEPT Board since 2016 and was Chair of the Scientific Advisory Committee
- Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research...
Kevin Pfleger and Dr. "Congratulations to Perkins Professor Kevin Pfleger and Dr Elizabeth Johnstone who were awarded one of
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
adenocarcinoma, β-blockers and antihistamines: A clinical trial is needed Jillian G Baker , Erica K Sloan , Kevin Pfleger , Peter J McCormick , Cristina Salmerón , Paul A Insel PGxDB: an interactive web-platform
- 📰 GPCR Weekly News, September 11 to 17, 2023
Kevin Wright on his new position as Director of Targeted and Immuno-oncology at GPCR Therapeutics, our Kevin Wright Joins GPCR Therapeutics as Director of Targeted and Immuno-oncology Sosei Heptares Adds
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
Pfleger, K.D., R.M. Seeber, and K.A.
- Odorant receptors – a bit of smell for drug discovery
human tissues is highly variable from more than 60 ORs in the testis and only a few ORs in the liver (Flegel
- Glyco-sulfo hotspots in the chemokine receptor system
mediate ligand binding and signaling (Bannert N et al. 2001; Casarosa P et al. 2005; Gao J et al. 2003; Fieger
